CDKN2B-AS1 and myocardial infarction: For example, CDKN2B-AS1 (or ANRIL) and MALAT1 can be used to predict the development of left ventricular dysfunction as ANRIL was expressed at lower levels and MALAT1 expression was higher in patients with myocardial infarction than in healthy volunteers [345].